[1]
Hakimi, A.A. et al. 2013. The impact of metformin use on recurrence and cancer-specific survival in clinically localized high-risk renal cell carcinoma. Canadian Urological Association Journal. 7, 11-12 (Nov. 2013), e687–91. DOI:https://doi.org/10.5489/cuaj.1447.